BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Zeltia Group 

Calle Jose Abascal 2

Madrid    28003  Spain
Phone: 91-444-4500 Fax: 91-593-2954


SEARCH JOBS


Industry
Biotechnology






 Company News
Johnson & Johnson (JNJ) Withdraws Cancer Drug Petition; Zeltia Group (18494051.MA) to Miss $10 Million Yondelis Payment After U.S. Setback 5/2/2011 7:13:58 AM    More...
Zeltia Group (18494051.MA) Fails to Win U.K. Backing for Ovarian Cancer Drug 3/11/2011 6:33:17 AM    More...
74 Percent EBITDA Improvement at Zeltia Group (18494051.MA) in 2010 2/25/2011 9:17:41 AM    More...
Australian Regulator Rejects Zeltia Group (18494051.MA)'s Cancer Drug Yondelis 11/12/2010 6:59:01 AM    More...
Zeltia Group (18494051.MA): Yondelis(R) Sales Expanded by 70 Percent 10/29/2010 7:03:53 AM    More...
Zeltia Group (18494051.MA) Reports Positive EBITDA in First Half of 2010 7/29/2010 11:53:18 AM    More...
Zeltia Group (18494051.MA) Achieves Consolidated EBITDA Break-Even in 1Q10 4/30/2010 12:47:00 PM    More...
Zeltia Group (18494051.MA) Achieves Consolidated EBITDA Break-Even in 1Q10 4/30/2010 10:20:34 AM    More...
Zeltia Group (18494051.MA) Revenues up 53.3% 2/26/2010 6:57:02 AM    More...
EU Agency Backs Zeltia Group (18494051.MA) Drug for Ovarian Cancer 9/25/2009 6:52:19 AM    More...
1234

//-->